biosciences

Pacira BioSciences Confirms Receipt of Director Nominations from DOMA Perpetual

-- No Shareholder Action Required at This Time -- PARSIPPANY, N.J., March 14, 2025 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc.…

2 days ago

BluMaiden Biosciences Appoints New US-based Leadership to Accelerate Global Expansion

-       Dr. Terence Kelly named interim CEO and Prof. Damian O'Connell named Chair of the Scientific Advisory Board, joins Board…

4 weeks ago

Artelo Biosciences Announces New Data on ART12.11 Tablets Showing Improved Pharmacokinetics to Epidiolex

February 14, 2025 09:00 ET  | Source: Artelo Biosciences SOLANA BEACH, Calif., Feb. 14, 2025 (GLOBE NEWSWIRE) -- Artelo Biosciences,…

1 month ago

Cytek Biosciences to Report Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025

February 13, 2025 16:05 ET  | Source: Cytek Biosciences, Inc. FREMONT, Calif., Feb. 13, 2025 (GLOBE NEWSWIRE) -- Cytek Biosciences,…

1 month ago

Jade Biosciences to Participate in TD Cowens 45th Annual Health Care Conference and Jefferies Biotech on the Beach Summit

February 12, 2025 16:30 ET  | Source: Jade Biosciences VANCOUVER, British Columbia and SAN FRANCISCO, Feb. 12, 2025 (GLOBE NEWSWIRE)…

1 month ago

VJ Biosciences Debuts at 5th Annual Summit of Biologics Conferences with a Bold Vision for Biopharmaceutical Innovation

BANGALORE, India, Feb. 3, 2025 /PRNewswire/ -- New York-based VJ Group announced the launch of its newest venture, VJ Bio,…

1 month ago

Persephone Biosciences Announces First Subject Enrolled in ARTEMIS Clinical Trial of New Infant Synbiotic

SAN DIEGO, Jan. 23, 2025 (GLOBE NEWSWIRE) -- Persephone Biosciences Inc., a commercial company restoring and reinvigorating the human gut…

2 months ago

PACIRA BIOSCIENCES SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Pacira BioSciences, Inc. – PCRX

NEW ORLEANS, Jan. 22, 2025 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until…

2 months ago

Solid Biosciences Outlines Key Priorities for Advancing Diversified Neuromuscular and Cardiac Development Pipeline and Establishing Leadership in Precision Genetic Medicines

January 15, 2025 16:05 ET  | Source: Solid Biosciences Inc. - Duchenne: Dosed four patients in INSPIRE DUCHENNE clinical trial;…

2 months ago

Assembly Biosciences Reports Interim Phase 1b Results from Clinical Trial Evaluating Next-Generation Capsid Assembly Modulator Candidate ABI-4334 in Chronic Hepatitis B

– ABI-4334 was well-tolerated with a favorable safety profile and half-life supporting once-daily oral dosing observed – – In the…

3 months ago